Expression patterns of Trk-A, Trk-B, GRP78, and p75NRT in olfactory neuroblastoma

Human Pathology

Volumn 40, Issue 9, 2009, Pages 1330-1335

  Weinreb, Ilan ^a,b   Goldstein, David ^a   Irish, Jonathan ^a   Perez Ordonez, Bayardo ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hyams; Neurotrophin receptors; Olfactory neuroblastoma; Prognosis; Trk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLUCOSE REGULATED PROTEIN 78; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CORRELATION ANALYSIS; ESTHESIONEUROBLASTOMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADULT; AGED; CHILD; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTOR, TRKB; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 68349144121     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.02.001     Document Type: Article

References (23)

1. Wenig B.M., Dulguerov P., Kapadia S.B., Prasad M.L., Fanburg-Smith J.C., and Thompson L.D. Neuroectodermal tumours. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours (2005), IARC Press, Lyon 66-70
2. Hyams V.J., Batsakis J.G., and Michaels L. Tumors of the upper respiratory tract and ear. 2nd series ed. (1988), Armed Forces. Institute of Pathology, Washington
3. Zhao S.P., and Zhou X.F. Co-expression of trkA and p75 neurotrophin receptor in extracranial olfactory neuroblastoma cells. Neuropathol Appl Neurobiol 28 (2002) 301-307
4. Hsu W.M., Hsieh F.J., Jeng Y.M., et al. GRP78 expression correlates with histologic differentiation and favorable prognosis in neuroblastic tumors. Int J Cancer 113 (2005) 920-927
5. Brodeur G.M., Nakagawara A., Yamashiro D.J., et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 31 (1997) 49-55
6. van Noesel M.M., and Versteeg R. Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 325 (2004) 1-15
7. Miyamoto R.C., Gleich L.L., Biddinger P.W., and Gluckman J.L. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 110 (2000) 1262-1265
8. Whang-Peng J., Freter C.E., Knutsen T., Nanfro J.J., and Gazdar A. Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 29 (1987) 155-157
9. Sorensen P.H., Wu J.K., Berean K.W., et al. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci U S A 93 (1996) 1038-1043
10. Argani P., Perez-Ordonez B., Xiao H., Caruana S.M., Huvos A.G., and Ladanyi M. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol 22 (1998) 391-398
11. Kumar S., Perlman E., Pack S., et al. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family. Hum Pathol 30 (1999) 1356-1360
12. Mezzelani A., Tornielli S., Minoletti F., Pierotti M.A., Sozzi G., and Pilotti S. Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group. Br J Cancer 81 (1999) 586-591
13. Papadaki H., Kounelis S., Kapadia S.B., Bakker A., Swalsky P.A., and Finkelstein S.D. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma. Am J Surg Pathol 20 (1996) 715-721
14. Guled M., Myllykangas S., Frierson Jr. H.F., Mills S.E., Knuutila S., and Stelow E.B. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol 21 (2008) 770-778
15. Schulte J.H., Schramm A., Klein-Hitpass L., et al. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 24 (2005 6) 165-177
16. Krüttgen A., Schneider I., and Weis J. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol 16 (2006) 304-310
17. Shimada H., Nakagawa A., Peters J., et al. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance. Cancer 101 (2004) 1873-1881
18. Eggert A., Grotzer M.A., Ikegaki N., et al. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma. Med Pediatr Oncol 35 (2000) 569-572
19. Bahrami A., Gown A.M., Baird G.S., Hicks M.J., and Folpe A.L. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol 21 (2008) 795-806
20. Donovan M.J., Hempstead B.L., Horvath C., Chao M.V., and Schofield D. Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am J Pathol 143 (1993) 1560-1567
21. Xu X., Tahan S.R., Pasha T.L., and Zhang P.J. Expression of neurotrophin receptor Trk-C in nevi and melanomas. J Cutan Pathol 30 (2003) 318-322
22. Nogueira E., Navarro S., Pellín A., and Llombart-Bosch A. Activation of TRK genes in Ewing's sarcoma. Trk A receptor expression linked to neural differentiation. Diagn Mol Pathol 6 (1997) 10-16
23. Gimm O., Dziema H., Brown J., et al. Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants. Int J Cancer 92 (2001) 70-74